Cargando…

Polymorphic variants of IGF2BP3 and SENCR have an impact on predisposition and/or progression of Ewing sarcoma

Ewing sarcoma (EWS), the second most common malignant bone tumor in children and adolescents, occurs abruptly without clear evidence of tumor history or progression. Previous association studies have identified some inherited variants associated with the risk of developing EWS but a common picture o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martinelli, Marcella, Mancarella, Caterina, Scapoli, Luca, Palmieri, Annalisa, De Sanctis, Paola, Ferrari, Cristina, Pasello, Michela, Zucchini, Cinzia, Scotlandi, Katia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634078/ https://www.ncbi.nlm.nih.gov/pubmed/36338681 http://dx.doi.org/10.3389/fonc.2022.968884

Ejemplares similares

CD99 polymorphisms significantly influence the probability to develop Ewing sarcoma in earlier age and patient disease progression
por: Martinelli, Marcella, et al.
Publicado: (2016)

CD99 triggering induces methuosis of Ewing sarcoma cells through IGF-1R/RAS/Rac1 signaling
por: Manara, Maria Cristina, et al.
Publicado: (2016)

IGF2BP3 From Physiology to Cancer: Novel Discoveries, Unsolved Issues, and Future Perspectives
por: Mancarella, Caterina, et al.
Publicado: (2020)

Unraveling the IGF System Interactome in Sarcomas Exploits Novel Therapeutic Options
por: Mancarella, Caterina, et al.
Publicado: (2021)

Extracellular vesicle-associated IGF2BP3 tunes Ewing sarcoma cell migration and affects PI3K/Akt pathway in neighboring cells
por: Mancarella, Caterina, et al.
Publicado: (2023)

Targeting ROCK2 rather than ROCK1 inhibits Ewing sarcoma malignancy
por: Pinca, Rosa Simona, et al.
Publicado: (2017)

ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis
por: Pasello, Michela, et al.
Publicado: (2022)

Correction to: ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis
por: Pasello, Michela, et al.
Publicado: (2022)

Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 Influences Sensitivity to Anti-IGF System Agents Through the Translational Regulation of IGF1R
por: Mancarella, Caterina, et al.
Publicado: (2018)

Novel Regulators of the IGF System in Cancer
por: Mancarella, Caterina, et al.
Publicado: (2021)

Is There a Predisposition Gene for Ewing's Sarcoma?
por: Randall, R. L., et al.
Publicado: (2010)

miR-214-3p Is Commonly Downregulated by EWS-FLI1 and by CD99 and Its Restoration Limits Ewing Sarcoma Aggressiveness
por: De Feo, Alessandra, et al.
Publicado: (2022)

Serum levels of IGF-1 and IGF-BP3 are associated with event-free survival in adult Ewing sarcoma patients treated with chemotherapy
por: de Groot, Stefanie, et al.
Publicado: (2017)

PROTAC-Based Protein Degradation as a Promising Strategy for Targeted Therapy in Sarcomas
por: Mancarella, Caterina, et al.
Publicado: (2023)

Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 Modulates Aggressiveness of Ewing Sarcoma by Regulating the CD164-CXCR4 Axis
por: Mancarella, Caterina, et al.
Publicado: (2020)

Unraveling the Resistance of IGF-Pathway Inhibition in Ewing Sarcoma
por: de Groot, Stefanie, et al.
Publicado: (2020)

EHD1-dependent traffic of IGF-1 receptor to the cell surface is essential for Ewing sarcoma tumorigenesis and metastasis
por: Chakraborty, Sukanya, et al.
Publicado: (2023)

CIC-Rearranged Sarcomas: An Intriguing Entity That May Lead the Way to the Comprehension of More Common Cancers
por: Mancarella, Caterina, et al.
Publicado: (2022)

Non-syndromic Cleft Palate: An Overview on Human Genetic and Environmental Risk Factors
por: Martinelli, Marcella, et al.
Publicado: (2020)

CD99 at the crossroads of physiology and pathology
por: Pasello, Michela, et al.
Publicado: (2018)

CD99: A Cell Surface Protein with an Oncojanus Role in Tumors
por: Manara, Maria Cristina, et al.
Publicado: (2018)

Impact of ABC Transporters in Osteosarcoma and Ewing’s Sarcoma: Which Are Involved in Chemoresistance and Which Are Not?
por: Serra, Massimo, et al.
Publicado: (2021)

Transcriptome profiling of Ewing sarcomas – treatment resistance pathways and IGF‐dependency
por: Chen, Yi, et al.
Publicado: (2020)

Exosomes from CD99-deprived Ewing sarcoma cells reverse tumor malignancy by inhibiting cell migration and promoting neural differentiation
por: De Feo, Alessandra, et al.
Publicado: (2019)

A Role for the Long Noncoding RNA SENCR in Commitment and Function of Endothelial Cells
por: Boulberdaa, Mounia, et al.
Publicado: (2016)

An integrated analysis of miRNA and gene copy numbers in xenografts of Ewing's sarcoma
por: Mosakhani, Neda, et al.
Publicado: (2012)

IGF1R immunohistochemistry in Ewing’s sarcoma as predictor of response to targeted therapy
por: Gonzalez, Elizabeth, et al.
Publicado: (2020)

Lamin A and the LINC complex act as potential tumor suppressors in Ewing Sarcoma
por: Chiarini, Francesca, et al.
Publicado: (2022)

Combined use of expression and CGH arrays pinpoints novel candidate genes in Ewing sarcoma family of tumors
por: Savola, Suvi, et al.
Publicado: (2009)

Lab-Test(®) 4: Dental caries and bacteriological analysis
por: Cura, Francesca, et al.
Publicado: (2012)

Germline predisposition to pediatric Ewing sarcoma is characterized by inherited pathogenic variants in DNA damage repair genes
por: Gillani, Riaz, et al.
Publicado: (2022)

ERG deregulation induces IGF-1R expression in prostate cancer cells and affects sensitivity to anti-IGF-1R agents
por: Mancarella, Caterina, et al.
Publicado: (2015)

IGF1R Signaling in Ewing Sarcoma Is Shaped by Clathrin-/Caveolin-Dependent Endocytosis
por: Martins, Ana Sofia, et al.
Publicado: (2011)

Characterization of Human Mesenchymal Stem Cells from Ewing Sarcoma Patients. Pathogenetic Implications
por: Amaral, Ana Teresa, et al.
Publicado: (2014)

High Expression of Complement Component 5 (C5) at Tumor Site Associates with Superior Survival in Ewing's Sarcoma Family of Tumour Patients
por: Savola, Suvi, et al.
Publicado: (2011)

Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 Sarcoma
por: Carrabotta, Marianna, et al.
Publicado: (2022)

ROCK2 deprivation leads to the inhibition of tumor growth and metastatic potential in osteosarcoma cells through the modulation of YAP activity
por: Zucchini, Cinzia, et al.
Publicado: (2019)

Cutaneous Ewing Sarcoma and Ewing Sarcoma of the Bone: Distinct Diseases
por: Tavakkoli, Montreh, et al.
Publicado: (2018)

Targeting Glutathione-S Transferase Enzymes in Musculoskeletal Sarcomas: A Promising Therapeutic Strategy
por: Pasello, Michela, et al.
Publicado: (2011)

Association of the rs555172 polymorphism in SENCR long non-coding RNA and atherosclerotic coronary artery disease
por: Shahmoradi, Nahid, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_hf02c21k2j80gmnh4pgfotqje3